GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Q32 Bio Inc (NAS:QTTB) » Definitions » Price-to-Tangible-Book

Q32 Bio (Q32 Bio) Price-to-Tangible-Book : 6.80 (As of Jun. 04, 2024)


View and export this data going back to 2024. Start your Free Trial

What is Q32 Bio Price-to-Tangible-Book?

As of today (2024-06-04), Q32 Bio's share price is $27.80. Q32 Bio's Tangible Book per Share of Mar. 2024 for the quarter that ended in Mar. 2024 was $4.09. Hence, Q32 Bio's Price to Tangible Book Ratio of today is 6.80.

The historical rank and industry rank for Q32 Bio's Price-to-Tangible-Book or its related term are showing as below:

QTTB' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 4.17   Med: 4.17   Max: 6.91
Current: 6.8

During the past 3 years, Q32 Bio's highest Price to Tangible Book Ratio was 6.91. The lowest was 4.17. And the median was 4.17.

QTTB's Price-to-Tangible-Book is ranked worse than
79.44% of 1221 companies
in the Biotechnology industry
Industry Median: 2.81 vs QTTB: 6.80

A closely related ratio is called PB Ratio. As of today, Q32 Bio's share price is $27.80. Q32 Bio's Book Value per Sharefor the quarter that ended in Mar. 2024 was $4.09. Hence, Q32 Bio's P/B Ratio of today is 6.80.

Q32 Bio Price-to-Tangible-Book Historical Data

The historical data trend for Q32 Bio's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Q32 Bio Price-to-Tangible-Book Chart

Q32 Bio Annual Data
Trend Dec21 Dec22 Dec23
Price-to-Tangible-Book
- - -

Q32 Bio Quarterly Data
Dec21 Sep22 Dec22 Mar23 Sep23 Dec23 Mar24
Price-to-Tangible-Book Get a 7-Day Free Trial - - - - 4.17

Competitive Comparison of Q32 Bio's Price-to-Tangible-Book

For the Biotechnology subindustry, Q32 Bio's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Q32 Bio's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Q32 Bio's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Q32 Bio's Price-to-Tangible-Book falls into.


Q32 Bio Price-to-Tangible-Book Calculation

Q32 Bio's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Mar. 2024 )
=27.80/4.088
=6.80

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price to Tangible Book=Market Cap/Tangible Equity
=Market Cap/(Total Stockholders Equity-Preferred Stock-Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Q32 Bio Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Q32 Bio's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Q32 Bio (Q32 Bio) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Q32 Bio Inc (NAS:QTTB) » Definitions » Price-to-Tangible-Book
Comparable Companies
Traded in Other Exchanges
N/A
Address
830 Winter Street, Waltham, MA, USA, 02451
Website
https://www.q32bio.com
Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to effectively and safely restore healthy immune balance in patients with autoimmune & inflammatory diseases driven by pathological immune dysfunction. Q32 is advancing antibody-based therapeutic candidates designed to target two central pathways of adaptive & innate immunity. The adaptive immune system is largely composed of T- & B-cell mediated cellular & antibody responses, while the innate immune system is the body's first line of defense employing leukocytes that are responsible for clearing pathogens and cellular debris and modulating T- & B-cell function. ADX-097, the lead product candidate from Q32's complement inhibitor platform, is a humanized anti-C3d monoclonal antibody fusion protein.

Q32 Bio (Q32 Bio) Headlines

From GuruFocus

Q32 Bio Appoints Lee Kalowski as President & Chief Financial Officer

By PRNewswire • 04-03-2024